annual cash & cash equivalents:
$163.77M-$77.05M(-32.00%)Summary
- As of today (May 29, 2025), NVCR annual cash & cash equivalents is $163.77 million, with the most recent change of -$77.05 million (-32.00%) on December 31, 2024.
- During the last 3 years, NVCR annual cash & cash equivalents has fallen by -$45.03 million (-21.57%).
- NVCR annual cash & cash equivalents is now -32.00% below its all-time high of $240.82 million, reached on December 31, 2023.
Performance
NVCR Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$127.28M-$36.49M(-22.28%)Summary
- As of today (May 29, 2025), NVCR quarterly cash & cash equivalents is $127.28 million, with the most recent change of -$36.49 million (-22.28%) on March 31, 2025.
- Over the past year, NVCR quarterly cash & cash equivalents has dropped by -$326.48 million (-71.95%).
- NVCR quarterly cash & cash equivalents is now -81.55% below its all-time high of $689.84 million, reached on September 30, 2021.
Performance
NVCR quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NVCR Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.0% | -72.0% |
| 3 y3 years | -21.6% | -33.3% |
| 5 y5 years | -7.6% | -30.0% |
NVCR Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.0% | +42.0% | -72.0% | +10.4% |
| 5 y | 5-year | -32.0% | +42.0% | -81.5% | +10.4% |
| alltime | all time | -32.0% | +184.3% | -81.5% | +120.9% |
NVCR Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $127.28M(-22.3%) |
| Dec 2024 | $163.77M(-32.0%) | $163.77M(-11.7%) |
| Sep 2024 | - | $185.42M(+12.5%) |
| Jun 2024 | - | $164.80M(-63.7%) |
| Mar 2024 | - | $453.76M(+88.4%) |
| Dec 2023 | $240.82M(+108.8%) | $240.82M(+55.5%) |
| Sep 2023 | - | $154.86M(-1.3%) |
| Jun 2023 | - | $156.98M(-15.6%) |
| Mar 2023 | - | $185.96M(+61.2%) |
| Dec 2022 | $115.33M(-44.8%) | $115.33M(-52.7%) |
| Sep 2022 | - | $243.81M(-33.6%) |
| Jun 2022 | - | $367.01M(+92.4%) |
| Mar 2022 | - | $190.74M(-8.7%) |
| Dec 2021 | $208.80M(-11.0%) | $208.80M(-69.7%) |
| Sep 2021 | - | $689.84M(+97.6%) |
| Jun 2021 | - | $349.12M(+11.0%) |
| Mar 2021 | - | $314.55M(+34.0%) |
| Dec 2020 | $234.67M(+32.3%) | $234.67M(+0.1%) |
| Sep 2020 | - | $234.46M(+19.1%) |
| Jun 2020 | - | $196.78M(+8.2%) |
| Mar 2020 | - | $181.92M(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $177.32M(+26.1%) | $177.32M(-14.8%) |
| Sep 2019 | - | $208.03M(+15.5%) |
| Jun 2019 | - | $180.07M(+18.4%) |
| Mar 2019 | - | $152.07M(+8.1%) |
| Dec 2018 | $140.62M(+78.9%) | $140.62M(+14.4%) |
| Sep 2018 | - | $122.96M(+7.4%) |
| Jun 2018 | - | $114.46M(+2.6%) |
| Mar 2018 | - | $111.60M(+42.0%) |
| Dec 2017 | $78.59M(-21.2%) | $78.59M(-4.3%) |
| Sep 2017 | - | $82.10M(+2.4%) |
| Jun 2017 | - | $80.19M(-5.2%) |
| Mar 2017 | - | $84.59M(-15.2%) |
| Dec 2016 | $99.78M(-16.4%) | $99.78M(-13.9%) |
| Sep 2016 | - | $115.82M(+43.2%) |
| Jun 2016 | - | $80.87M(-30.2%) |
| Mar 2016 | - | $115.93M(-2.9%) |
| Dec 2015 | $119.42M(+107.3%) | $119.42M(+8.2%) |
| Sep 2015 | - | $110.32M(+3.6%) |
| Jun 2015 | - | $106.51M(+84.9%) |
| Dec 2014 | $57.61M(-67.2%) | $57.61M |
| Dec 2013 | $175.89M | - |
FAQ
- What is NovoCure Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NovoCure Limited?
- What is NovoCure Limited annual cash & cash equivalents year-on-year change?
- What is NovoCure Limited quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for NovoCure Limited?
- What is NovoCure Limited quarterly cash & cash equivalents year-on-year change?
What is NovoCure Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of NVCR is $163.77M
What is the all time high annual cash & cash equivalents for NovoCure Limited?
NovoCure Limited all-time high annual cash & cash equivalents is $240.82M
What is NovoCure Limited annual cash & cash equivalents year-on-year change?
Over the past year, NVCR annual cash & cash equivalents has changed by -$77.05M (-32.00%)
What is NovoCure Limited quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of NVCR is $127.28M
What is the all time high quarterly cash & cash equivalents for NovoCure Limited?
NovoCure Limited all-time high quarterly cash & cash equivalents is $689.84M
What is NovoCure Limited quarterly cash & cash equivalents year-on-year change?
Over the past year, NVCR quarterly cash & cash equivalents has changed by -$326.48M (-71.95%)